Criteria to define rare diseases and orphan drugs: a systematic review protocol
Introduction Rare diseases (RDs) are often chronic and progressive life-threatening medical conditions that affect a low percentage of the population compared with other diseases. These conditions can be treated with medications known as orphan drugs (ODs). Unfortunately, there is no universal defin...
Saved in:
Main Authors: | Katie Kerr, Ghada Mohammed Abozaid, Amy McKnight, Hussain A Al-Omar |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-07-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/7/e062126.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rare or orphan diseases. A review study
by: Ener Mantilla Horna, et al.
Published: (2025-01-01) -
A proposed conceptual model for orphan drug market entry
by: Nataša Jalen, et al.
Published: (2024-11-01) -
Defining polypharmacy in the elderly: a systematic review protocol
by: Seyede Salehe Mortazavi, et al.
Published: (2016-03-01) -
Orphans in Mediterranean antiquity and early Christianity
by: J. T. Fitzgerald
Published: (2016-06-01) -
An Orphan Colony of Polistes Pallipes Lepel
by: C. H. Turner
Published: (1912-01-01)